Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mohammed Orloff

Concepts (236)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genetic Predisposition to Disease
11
2024
507
1.100
 Why?
Germ-Line Mutation
9
2013
61
1.080
 Why?
Hamartoma Syndrome, Multiple
8
2012
15
1.080
 Why?
PTEN Phosphohydrolase
13
2015
55
1.050
 Why?
Barrett Esophagus
2
2019
30
1.020
 Why?
Esophageal Neoplasms
2
2019
101
0.940
 Why?
Adenocarcinoma
3
2019
402
0.840
 Why?
Haplotypes
3
2020
84
0.790
 Why?
Homozygote
3
2019
57
0.670
 Why?
Polymorphism, Single Nucleotide
9
2021
486
0.670
 Why?
Carcinoma, Non-Small-Cell Lung
1
2020
156
0.630
 Why?
Proto-Oncogene Proteins c-akt
4
2012
157
0.600
 Why?
Databases, Factual
1
2020
655
0.570
 Why?
Alleles
6
2021
250
0.460
 Why?
Lung Neoplasms
3
2020
609
0.450
 Why?
Phosphatidylinositol 3-Kinases
2
2012
140
0.420
 Why?
Genotype
6
2021
533
0.410
 Why?
Scavenger Receptors, Class A
1
2011
39
0.380
 Why?
Extracellular Matrix Proteins
1
2011
70
0.380
 Why?
Genetic Variation
3
2021
215
0.300
 Why?
Transcription Factors
1
2011
564
0.300
 Why?
Breast Neoplasms
7
2017
1184
0.290
 Why?
Humans
37
2024
50251
0.290
 Why?
Thyroid Neoplasms
4
2012
111
0.290
 Why?
Heart Defects, Congenital
2
2024
584
0.280
 Why?
Case-Control Studies
4
2024
1132
0.270
 Why?
Genes, Wilms Tumor
1
2005
1
0.250
 Why?
Population
1
2005
8
0.250
 Why?
Gene Frequency
3
2020
95
0.250
 Why?
Glomerulosclerosis, Focal Segmental
1
2005
13
0.250
 Why?
Genome
2
2019
65
0.240
 Why?
Lamin Type A
1
2024
6
0.240
 Why?
Capacity Building
1
2024
18
0.230
 Why?
DNA Methylation
3
2024
550
0.220
 Why?
Adult
16
2024
13384
0.220
 Why?
Middle Aged
16
2021
12234
0.220
 Why?
Linkage Disequilibrium
2
2020
37
0.220
 Why?
Female
21
2024
26668
0.210
 Why?
Smoke-Free Policy
1
2022
8
0.210
 Why?
Tobacco Smoke Pollution
1
2022
47
0.200
 Why?
Inheritance Patterns
1
2021
22
0.190
 Why?
Phenotype
7
2021
732
0.190
 Why?
Models, Genetic
5
2013
170
0.180
 Why?
Risk Factors
5
2019
3608
0.180
 Why?
Male
15
2024
25483
0.180
 Why?
Succinate Dehydrogenase
2
2011
23
0.180
 Why?
Stilbenes
2
2010
55
0.180
 Why?
Aged
11
2020
9427
0.180
 Why?
Fires
1
2020
14
0.170
 Why?
Agriculture
1
2020
17
0.170
 Why?
Social Media
1
2021
96
0.170
 Why?
Tobacco Products
1
2021
122
0.170
 Why?
Aged, 80 and over
5
2020
3140
0.170
 Why?
Cluster Analysis
4
2013
235
0.170
 Why?
Exome
1
2019
46
0.160
 Why?
Genomics
1
2020
287
0.150
 Why?
Cell Proliferation
3
2010
1015
0.150
 Why?
Pulmonary Disease, Chronic Obstructive
1
2020
131
0.150
 Why?
Prostatic Neoplasms
2
2012
394
0.140
 Why?
Gene Expression Regulation, Neoplastic
3
2010
828
0.140
 Why?
Prognosis
2
2020
1959
0.140
 Why?
Endometrial Neoplasms
2
2015
138
0.140
 Why?
Leprosy
1
2016
6
0.130
 Why?
Asthma
1
2020
279
0.130
 Why?
Hypertension
1
2021
540
0.130
 Why?
Emergency Service, Hospital
1
2020
483
0.130
 Why?
Microsatellite Repeats
2
2012
37
0.130
 Why?
Regression Analysis
2
2017
393
0.130
 Why?
Aromatase
1
2015
8
0.120
 Why?
Tuberculosis
1
2016
147
0.120
 Why?
Arkansas
4
2024
1962
0.120
 Why?
Genetic Linkage
2
2011
26
0.110
 Why?
Young Adult
7
2021
4002
0.110
 Why?
Sirolimus
2
2010
62
0.110
 Why?
Adolescent
8
2021
6402
0.110
 Why?
Genome-Wide Association Study
2
2012
166
0.110
 Why?
Bone Morphogenetic Protein Receptors, Type I
1
2013
1
0.110
 Why?
Smad4 Protein
1
2013
5
0.110
 Why?
Genetic Testing
2
2010
118
0.110
 Why?
Cohort Studies
3
2012
1397
0.110
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2012
18
0.110
 Why?
Colonic Polyps
1
2013
35
0.110
 Why?
Mitochondrial Diseases
1
2012
42
0.100
 Why?
Receptors, Cell Surface
1
2013
125
0.100
 Why?
Codon, Nonsense
1
2012
26
0.100
 Why?
Flavin-Adenine Dinucleotide
1
2011
5
0.100
 Why?
NAD
1
2011
43
0.100
 Why?
Antigens, CD
1
2013
221
0.100
 Why?
Genes, p53
1
2011
51
0.100
 Why?
DNA, Neoplasm
1
2012
147
0.100
 Why?
Siblings
1
2011
34
0.100
 Why?
Mutation, Missense
1
2012
106
0.100
 Why?
Taxoids
1
2011
37
0.100
 Why?
Gene Expression Profiling
3
2012
1041
0.090
 Why?
Adenoma
1
2012
111
0.090
 Why?
Risk
1
2012
315
0.090
 Why?
Colorectal Neoplasms
2
2012
238
0.090
 Why?
Software
1
2013
273
0.090
 Why?
Intestinal Polyps
1
2010
7
0.090
 Why?
Receptors, Androgen
1
2010
46
0.090
 Why?
Cephalometry
1
2010
18
0.090
 Why?
Tumor Microenvironment
1
2012
233
0.090
 Why?
Gene Dosage
1
2009
78
0.080
 Why?
Head
1
2010
73
0.080
 Why?
Carcinoma, Transitional Cell
1
2010
52
0.080
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
143
0.080
 Why?
Patient Selection
1
2010
252
0.080
 Why?
Cell Communication
1
2009
69
0.080
 Why?
Drug Resistance, Neoplasm
1
2011
316
0.080
 Why?
Age Factors
1
2012
1088
0.080
 Why?
Urinary Bladder Neoplasms
1
2010
156
0.080
 Why?
Immunohistochemistry
1
2011
978
0.080
 Why?
Smoking
1
2012
507
0.080
 Why?
Prevalence
2
2021
953
0.070
 Why?
Chromosome Mapping
2
2021
156
0.070
 Why?
Prospective Studies
4
2017
2379
0.070
 Why?
Mass Screening
1
2010
346
0.070
 Why?
Rural Population
2
2022
541
0.070
 Why?
Cell Line, Tumor
4
2011
1418
0.070
 Why?
Physical Chromosome Mapping
1
2005
8
0.070
 Why?
Multiple Myeloma
1
2020
2958
0.070
 Why?
Antineoplastic Agents
2
2011
1186
0.060
 Why?
Frasier Syndrome
1
2005
1
0.060
 Why?
Denys-Drash Syndrome
1
2005
3
0.060
 Why?
Exons
1
2005
95
0.060
 Why?
Child
5
2020
6854
0.060
 Why?
CpG Islands
1
2024
107
0.060
 Why?
Models, Theoretical
1
2005
174
0.060
 Why?
Gene Expression Regulation
1
2008
978
0.060
 Why?
Mutation
2
2010
1296
0.050
 Why?
Biopsy
1
2005
591
0.050
 Why?
Polyproteins
1
2022
2
0.050
 Why?
Child, Preschool
3
2020
3877
0.050
 Why?
Risk Assessment
2
2021
1257
0.050
 Why?
Phosphoproteins
1
2022
108
0.050
 Why?
RNA, Viral
1
2022
125
0.050
 Why?
Cardiomyopathy, Hypertrophic, Familial
1
2021
5
0.050
 Why?
United States Food and Drug Administration
1
2021
92
0.050
 Why?
Membrane Glycoproteins
1
2022
247
0.050
 Why?
Azacitidine
1
2020
34
0.050
 Why?
Nutrition Surveys
1
2021
103
0.050
 Why?
Loss of Heterozygosity
2
2012
77
0.050
 Why?
United States
2
2021
4887
0.050
 Why?
Stromal Cells
2
2012
72
0.040
 Why?
TOR Serine-Threonine Kinases
2
2010
77
0.040
 Why?
Nicotine
1
2021
186
0.040
 Why?
Self Report
1
2021
203
0.040
 Why?
Pedigree
2
2010
125
0.040
 Why?
Seasons
1
2020
82
0.040
 Why?
Air Pollution
1
2020
41
0.040
 Why?
Neoplasms
1
2009
1250
0.040
 Why?
Odds Ratio
1
2021
548
0.040
 Why?
Signal Transduction
3
2010
1624
0.040
 Why?
Phosphorylation
2
2010
534
0.040
 Why?
Gene Expression
2
2012
615
0.040
 Why?
Sensitivity and Specificity
2
2012
869
0.040
 Why?
Predictive Value of Tests
2
2012
914
0.040
 Why?
Dexamethasone
1
2020
431
0.040
 Why?
Treatment Outcome
2
2020
5186
0.040
 Why?
Infant
2
2020
3560
0.040
 Why?
Angiopoietin-2
1
2017
15
0.040
 Why?
Angiopoietin-1
1
2017
16
0.040
 Why?
Receptor, TIE-2
1
2017
16
0.040
 Why?
Fibroblast Growth Factor 2
1
2017
34
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2017
44
0.040
 Why?
Dose-Response Relationship, Drug
2
2010
1377
0.040
 Why?
Matrix Metalloproteinase 9
1
2017
89
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
202
0.030
 Why?
Cross-Sectional Studies
1
2021
1557
0.030
 Why?
Neoadjuvant Therapy
1
2017
118
0.030
 Why?
Neovascularization, Pathologic
1
2017
162
0.030
 Why?
HapMap Project
1
2015
3
0.030
 Why?
Introns
1
2015
48
0.030
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
994
0.030
 Why?
Pilot Projects
1
2016
704
0.030
 Why?
Peutz-Jeghers Syndrome
1
2013
2
0.030
 Why?
Databases, Genetic
1
2013
88
0.030
 Why?
Genome, Human
1
2013
111
0.030
 Why?
Validation Studies as Topic
1
2012
10
0.030
 Why?
Penetrance
1
2012
6
0.030
 Why?
Neoplasm Grading
1
2012
123
0.020
 Why?
Genetic Association Studies
1
2012
116
0.020
 Why?
Anthracyclines
1
2011
29
0.020
 Why?
Vincristine
1
2011
88
0.020
 Why?
Inhibitory Concentration 50
1
2010
75
0.020
 Why?
Formazans
1
2010
2
0.020
 Why?
Tetrazolium Salts
1
2010
14
0.020
 Why?
Paclitaxel
1
2011
85
0.020
 Why?
Immunoblotting
1
2010
117
0.020
 Why?
Androgen Antagonists
1
2010
11
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.020
 Why?
Drug Synergism
1
2010
151
0.020
 Why?
HEK293 Cells
1
2011
225
0.020
 Why?
Michigan
1
2010
17
0.020
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2010
16
0.020
 Why?
Mitogen-Activated Protein Kinases
1
2010
155
0.020
 Why?
Point Mutation
1
2010
65
0.020
 Why?
Epithelial Cells
1
2012
208
0.020
 Why?
Neoplasm Transplantation
1
2010
85
0.020
 Why?
Androgens
1
2010
69
0.020
 Why?
Kidney Neoplasms
1
2012
175
0.020
 Why?
Heredity
1
2009
2
0.020
 Why?
Transplantation, Heterologous
1
2010
75
0.020
 Why?
BRCA2 Protein
1
2009
16
0.020
 Why?
Endoscopy, Gastrointestinal
1
2010
74
0.020
 Why?
Adenosine Triphosphate
1
2011
234
0.020
 Why?
BRCA1 Protein
1
2009
32
0.020
 Why?
Comparative Genomic Hybridization
1
2009
47
0.020
 Why?
Polymerase Chain Reaction
1
2011
455
0.020
 Why?
Proteins
1
2012
345
0.020
 Why?
Mice, Nude
1
2010
254
0.020
 Why?
Chi-Square Distribution
1
2010
278
0.020
 Why?
Cell Cycle
1
2010
232
0.020
 Why?
Algorithms
1
2013
618
0.020
 Why?
Protein Binding
1
2011
668
0.020
 Why?
Gene Deletion
1
2010
270
0.020
 Why?
Diagnosis, Differential
1
2012
1043
0.020
 Why?
Cell Survival
1
2010
602
0.020
 Why?
Incidence
1
2012
986
0.020
 Why?
Neoplasm Invasiveness
1
2009
268
0.020
 Why?
Cell Transformation, Neoplastic
1
2009
179
0.020
 Why?
Neoplastic Stem Cells
1
2009
103
0.020
 Why?
Promoter Regions, Genetic
1
2010
475
0.020
 Why?
Membrane Proteins
1
2010
353
0.020
 Why?
Neoplasm Staging
1
2011
747
0.020
 Why?
Microscopy, Confocal
1
2008
89
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2009
412
0.020
 Why?
Cell Differentiation
1
2011
652
0.020
 Why?
Chromosome Aberrations
1
2009
297
0.020
 Why?
Survival Rate
1
2010
902
0.020
 Why?
Registries
1
2010
513
0.020
 Why?
Chromosomes, Human
1
2005
41
0.020
 Why?
Time Factors
1
2010
2911
0.010
 Why?
Reproducibility of Results
1
2005
1189
0.010
 Why?
Mice
1
2010
5770
0.010
 Why?
Animals
1
2010
13285
0.010
 Why?
Orloff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (236) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department